Georgia is sliding towards autocracy after government moves to force through bill on ‘foreign agents’ 
Elon Musk says ketamine can get you out of a ‘negative frame of mind’. What does the research say? 
Eye infections might seem like a minor complaint – but in some cases they can cause blindness and even death 
Microsoft to Set Up Its First Azure Data Center in Thailand With Investment in AI 
OpenAI CEO Sam Altman Pushes for AI Policy on Capitol Hill Visit After Middle East Tour 
Electric vehicles are usually safer for their occupants – but not necessarily for everyone else 
Supreme Court appears open to Starbucks’ claims in labor-organizing case 
Kakao Gets Approval to Acquire SM Entertainment Controlling Stake 
Comcast Drops Bally Sports Channels, Stops Broadcast of MLB Team Games 
KFC Shutters Over 100 Restaurants in Malaysia Over Tough Economic Conditions, Boycotts 
Does ejaculating often reduce your risk of prostate cancer? 
Major Victory for Bayer's Monsanto as Appeals Court Overturns $185 Million Award in Chemical Exposure Case 
Ensuring victims’ rights: The federal ombudsperson’s office is necessary but insufficient 
Eating some chocolate really might be good for you – here’s what the research says 
Honey is said to help with hay fever symptoms – here’s what the research says about this claim 
Male baldness is often trivialised – our research shows it should be taken seriously 
Chemours, Dupont De Nemours, and Corteva have announced a $110 million settlement with the U.S. state of Ohio to resolve claims linked to toxic "forever chemicals." This agreement aims to address concerns surrounding per- and polyfluoroalkyl substances (PFAS).
Nasdaq reported that the chemical has been associated with various health risks. The settlement covers costs related to the release of PFAS from the companies' facilities, including the Washington Works site situated along the Ohio-West Virginia border, as per Reuters.
Responsibility Distribution for Settlement Costs
According to the agreement, Chemours, a spin-off of DuPont, will bear 50% of the settlement costs, while DuPont will contribute approximately $39 million. Corteva, on the other hand, is expected to cover the remaining expenses. The resolution brings an end to Ohio's claims concerning the release of PFAS, affording the state an opportunity to address this issue comprehensively.
The resolution of the Ohio settlement emphasizes the importance of addressing the wide-reaching implications of PFAS contamination.
Notably, the settlement between the companies and Ohio has triggered a contingency provision outlined in Delaware's 2021 PFAS settlement with the same entities.
This provision requires an additional payment of $25 million to the state of Delaware and the original $50 million settlement if a similar agreement is reached within eight years with another state, amounting to over $50 million. This provision underlines the accountability held by chemical manufacturers in addressing the concerns associated with PFAS contamination.
Legal Battles Surrounding PFAS
Chemical manufacturers have faced numerous lawsuits in recent years regarding alleged PFAS contamination. In a significant ruling, a U.S. appeals court rejected a lower court's decision that would have allowed approximately 11.8 million Ohio residents to sue 10 PFAS manufacturers as a collective group. The legal landscape demonstrates the complexity surrounding PFAS-related claims and the efforts to hold responsible parties accountable for their actions.
In June, 3M agreed to a $10.3 billion settlement to address hundreds of claims alleging the company had contaminated public drinking water with PFAS. Similarly, Chemours, DuPont, and Corteva reached a separate settlement with U.S. water providers, amounting to $1.19 billion.
These settlements underscore the growing recognition within the industry regarding the need to address PFAS-related concerns and the responsibility manufacturers bear in ensuring the safety of their products and practices.
Photo: DuPont Newsroom
